Encompass Health Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Encompass Health Corporation on May 29, 2026. The filing details the completion of a private offering of senior notes and the subsequent use of proceeds to refinance existing debt obligations.
Key Financial Metrics and Transaction Details
- New Debt Issuance: $500 million aggregate principal amount of 5.875% Senior Notes due 2034.
- Net Proceeds: Approximately $491.2 million after deducting discounts and offering expenses.
- Interest Rate: 5.875% per annum, payable semiannually.
- Maturity Date: June 1, 2034.
- Debt Redemption: $400 million of 4.500% senior notes due 2028 redeemed at par.
- Revolving Credit Facility: $100 million repaid.
Material Changes Versus Prior Period
The filing does not provide comparative financial performance data (revenue, profit, or cash flow) as it is a transaction-specific report. The material change is the restructuring of the company's capital structure:
- Replacement of $400 million in lower-coupon debt (4.500%) with higher-coupon debt (5.875%) extending the maturity profile from 2028 to 2034.
- Reduction of liquidity drawn on the revolving credit facility by $100 million.
Outlook, Risks, and Covenants
Use of Proceeds: Net proceeds were utilized to redeem the 2028 notes, repay the revolving credit facility, and cover transaction fees.
Covenants: The Indenture limits the Company's ability to incur certain liens, enter into sale/leaseback transactions, or merge/consolidate assets, subject to exceptions.
Redemption Terms:
- Notes may be redeemed on or after June 1, 2029, at specified prices.
- Prior to June 1, 2029, redemption is possible at a "make-whole" premium.
- Up to 40% of the principal may be redeemed prior to June 1, 2029, using proceeds from equity offerings at 105.875% of principal.
Change of Control: Holders have the right to require repurchase at 101% of principal plus accrued interest upon a Change of Control.
Events of Default: Include payment defaults, covenant breaches, cross-defaults exceeding $100 million, bankruptcy, and judgments exceeding $100 million.
Investor Verification Checklist
- Verify the exact net proceeds received ($491.2 million) against the $500 million principal to confirm total issuance costs.
- Confirm the impact of the higher interest rate (5.875% vs. 4.500%) on future interest expense and EBITDA.
- Review the full text of the Indenture (Exhibit 4.1) for specific covenant exceptions and limitations.
- Assess the company's liquidity position post-transaction, specifically the remaining capacity on the revolving credit facility.
- Monitor the status of the subsidiary guarantees to ensure they remain in full force and effect.